Leisha A. Emens
Kaiser Permanente(US)Johns Hopkins University(US)Johns Hopkins Medicine(US)Kaiser Permanente South Sacramento Medical Center(US)University of Pittsburgh Medical Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Advanced Breast Cancer Therapies, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer(2018)4,264 cited
- → Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial(2019)1,172 cited
- → Breast Cancer Immunotherapy: Facts and Hopes(2017)917 cited
- → The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies(2015)804 cited
- → Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer(2018)779 cited
- → Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study(2017)